Lung Cancer Overview
As one of the largest and most clinically active lung cancer clinics in the southeast, UVA Cancer Center offers the latest in research and technology to diagnose and treat cancers of the lung and chest cavity. The management of lung cancer is increasingly complex and combinations of treatment including surgery, radiation and chemotherapy are often necessary to treat the various types of lung cancer successfully. UVA's multidisciplinary team of lung cancer experts works together to ensure each patient receives a treatment plan that is tailored to their specific condition and individual needs.
At UVA, we’re ranked among the top 50 hospitals in the nation by U.S. News & World Report. We’ve also received the highest possible performance rating for all nine common conditions and procedures reviewed, including lung cancer surgery.
New Low-Dose CT Screening Program for Lung Cancer
Lung cancer is one of the most common and deadly forms of cancer in the U.S., although when caught early, it is often treatable. Early screening could greatly improve your chances of surviving lung cancer.
Using a low-dose computed tomography (CT) scanner, doctors at UVA's Lung Cancer Screening program can see inside the lungs and detect cancer in patients who aren't showing symptoms. Call 855.200.LUNG or email email@example.com for more information.
Detecting & Targeting Lung Cancer
UVA Cancer Center strives to stay at the forefront of diagnostics and treatment for lung cancer using the most advanced technology, such as PET-CT for early detection, and lung-sparing and minimally-invasive procedures such as video-assisted surgery, high-dose rate (HDR) brachytherapy, stereotactic radiosurgery and We also perform whenever possible.
In addition to providing the latest in diagnostic and therapeutic procedures, UVA Cancer Center also offers chest x-rays, CT scans, MRI, nuclear medicine scans (PET-CT and PET scans), ultrasounds and more. Our multidisciplinary team performs bronchoscopy, endoscopy, esophagoscopy, esophageal dilatation, laser surgery, mediastinoscopy, bronchial dilatation and other services when needed for the diagnosis or treatment of lung cancer.
The lung cancer team at UVA Cancer Center pioneered a specialized technique called to help locate and remove small or indeterminate lung nodules that may appear in results from imaging procedures. During this procedure, the entire nodule is removed. If it is cancerous or has the potential to become malignant, radiotracer localization is a life-saving procedure. We have successfully performed this technique on 250 patients to date.
Improving Outcomes with Clinical Integration
Our multidisciplinary team of surgical and radiation oncologists, medical oncologists, pathologists, pulmonologists, radiologists, thoracic nurses and more, who are researchers and experts in their respective fields, offers a unique level of care and treatment options that patients don't have access to at other cancer centers in this region. By integrating research and clinical services, we're quickly translating our discoveries into effective treatments. Our expertise in the field of lung cancer translates into better outcomes and easier recoveries for our patients.
Featured Article: Novel Collaboration Leads to New Treatment Options
Sometimes the Most Promising Ideas Come from Unexpected Places
At UVA, John Bushweller, PhD, and his team have identified a unique class of inhibitors that may block abnormal cell growth in acute myeloid leukemia. What’s more, Bushweller and his team quickly realized their discovery could be a paradigm for treating other forms of cancer, including ovarian, colon, and lung. Read the full article (PDF) in Investing in Hope, back cover.
Research & Clinical Trials
Our researchers constantly work to understand the biology of lung cancer and the processes by which it spreads and becomes resistant to chemotherapy. Understanding the molecular changes that occur with lung cancer, we can develop clinical trials for new treatments that can be a successful option for some patients while serving future patients with potential effective new therapies.